Scorpius Holdings, Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 1305 E. HOUSTON STREET, SAN ANTONIO, TX, 78205
Mailing Address 1305 E. HOUSTON STREET, SAN ANTONIO, TX, 78205
Phone 919-240-7133
Fiscal Year End 1231
EIN 262844103
Financial Overview
FY2024
-$45.22M
Net Income
$51.04M
Total Assets
$-13.04
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | February 5, 2026 | View on SEC |
| 8-K Current report of material events | January 29, 2026 | View on SEC |
| 8-K Current report of material events | January 13, 2026 | View on SEC |
| 10-Q Quarterly financial report | January 12, 2026 | View on SEC |
| 8-K Current report of material events | December 3, 2025 | View on SEC |
| 8-K Current report of material events | December 2, 2025 | View on SEC |
| 8-K Current report of material events | November 25, 2025 | View on SEC |
| 8-K Current report of material events | November 17, 2025 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | November 12, 2025 | View on SEC |
| 8-K Current report of material events | October 21, 2025 | View on SEC |
Material Events
8-K Financial Distress January 29, 2026
High Impact
- Foreclosure of nearly all core business assets, including CDMO, R&D, and key operating subsidiaries.
- Company has effectively lost its primary revenue-generating operations and can no longer conduct core business activities.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.